Taurine

Taurine

SCHEMBL3480915

NCCS(=O)(=O)O.O=S(=O)(O)O

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Taurine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 3/20 0.93
LMNA P02545 2/20 0.93
SLC6A6 P31641 1/20 0.93
CYP2C19 P33261 1/20 0.93
APP P05067 1/20 0.63
PTGS1 P23219 1/20 0.45
PDE4A P27815 1/20 0.45
CA5A P35218 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
PMP22 Q01453 2/20 0.37
TSHR P16473 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
NT5E P21589 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Taurine SCHEMBL6363956 0.97 BLM (0.88) BLMLMNASLC6A6CYP2C19APP
Taurine SCHEMBL27565800 0.97 BLM (0.88) BLMLMNASLC6A6CYP2C19APP
Taurine SCHEMBL30193928 0.97 BLM (0.88) BLMLMNASLC6A6CYP2C19APP
Taurine SCHEMBL31366115 0.97 BLM (0.88) BLMLMNASLC6A6CYP2C19APP
Taurine SCHEMBL16859744 0.97 BLM (0.88) BLMLMNASLC6A6CYP2C19APP
Taurine SCHEMBL30191395 0.97
Taurine SCHEMBL30179154 0.97
Taurine SCHEMBL42632 0.97 BLM (1.00) BLMLMNASLC6A6CYP2C19APP
Taurine SCHEMBL23068 0.97
Taurine SCHEMBL11449240 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11015152-B2 Cleansing bars with taurine COLGATE-PALMOLIVE COMPANY (US) 2021-05-25 US claimed
CN-108713054-B Cleansing bar containing taurine 高露洁-棕榄公司 2020-09-29 CN claimed
EP-3383984-B1 CLEANSING BARS WITH TAURINE COLGATE PALMOLIVE CO (US) 2020-03-11 EP claimed
EP-3220879-B1 CLEANSING BARS WITH TAURINE COLGATE PALMOLIVE CO (US) 2020-03-04 EP claimed
CN-107001999-B Cleansing bar containing taurine 高露洁-棕榄公司 2020-02-07 CN claimed
US-10400199-B2 Cleansing bars with taurine COLGATE-PALMOLIVE COMPANY (US) 2019-09-03 US claimed
US-20180355293-A1 Cleansing Bars with Taurine COLGATE-PALMOLIVE COMPANY (US) 2018-12-13 US claimed
CN-108713054-A Cleansing bars containing taurine 高露洁-棕榄公司 2018-10-26 CN claimed
EP-3383984-A1 CLEANSING BARS WITH TAURINE Colgate-Palmolive Company (US) 2018-10-10 EP claimed
US-20170335251-A1 Cleansing Bars with Taurine COLGATE-PALMOLIVE COMPANY (US) 2017-11-23 US claimed
EP-3220879-A1 CLEANSING BARS WITH TAURINE Colgate-Palmolive Company (US) 2017-09-27 EP claimed
CN-107001999-A Cleansing bar containing taurine 高露洁-棕榄公司 2017-08-01 CN claimed
WO-2017095445-A1 CLEANSING BARS WITH TAURINE COLGATE-PALMOLIVE COMPANY (US) 2017-06-08 WO claimed
WO-2016089422-A1 CLEANSING BARS WITH TAURINE COLGATE-PALMOLIVE COMPANY (US) 2016-06-09 WO claimed
US-20240307481-A1 COMPOSITIONS AND METHODS FOR IMPROVING EYE FUNCTION CROSS III WILLIAM H (US) 2024-09-19 US disclosed
EP-3808734-B1 THE METHOD AND PRODUCTION SYSTEM FOR FULLY RECOVERING AND TREATING TAURINE MOTHER LIQUOR QIANGJIANG YONGAN PHARMACEUTICAL CO LTD (CN) 2022-03-30 EP disclosed
US-20220033743-A1 Solid Cleansing Compositions with Taurine and Methods Thereof COLGATE-PALMOLIVE COMPANY (US) 2022-02-03 US disclosed
EP-2239251-A1 Process for refining 2-aminoethanesulfonic acid from crude 2-aminoethane-sulfonic acid, 2-aminoethanesulfonic acid obtained there from and use thereof Rheln Pharma Consult GmbH (DE) 2010-10-13 EP disclosed
CN-101857558-A Make with extra care the method for 2-aminoethyl sulfonic acid, thus obtained 2-aminoethyl sulfonic acid and uses thereof by rough 2-aminoethyl sulfonic acid RHELN PHARMA CONSULT GMBH 2010-10-13 CN disclosed
CN-101466346-A Bleed-resistant colored microparticles CIBA HOLDING INC (CH) 2009-06-24 CN disclosed